Status:
COMPLETED
Efficacy and Safety of OMT on Asthmatics
Lead Sponsor:
Western University of Health Sciences
Conditions:
Asthma
Eligibility:
All Genders
18-55 years
Phase:
NA
Brief Summary
This is a pilot study in which the objective is to determine the feasibility of a randomized clinical trial investigating the safety and efficacy of OMT as an adjunctive treatment for patients with mi...
Detailed Description
Asthma is a leading cause of activity limitation and healthcare burden in the United States of America. The asthmatic population is in need of treatments that target reducing asthma symptoms, reduce t...
Eligibility Criteria
Inclusion
- Clinically diagnosed with mild to moderate asthma (Episodic symptoms included were airflow obstruction or airway hyper-responsiveness, and airflow obstruction that was at least partially reversible (based upon an increase in FEV1 or greater than or equal to 12% from baseline or by an increase of at least 10% of predicted FEV1 after inhalation of a short-acting bronchodilator)
Exclusion
- pneumonia
- COPD as a primary diagnosis
- pulmonary fibrosis
- smoking history
- inability to perform pulmonary function tests
- history of recent myocardial infarction or heart disease
- unable to respond to the questionnaire
- unable to provide informed consent
- pregnant
- using muscle relaxants
- Any contraindications to OMT such as: known bone metastases, severe osteoporosis, osteomyelitis, or fracture
Key Trial Info
Start Date :
December 11 2012
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 8 2015
Estimated Enrollment :
32 Patients enrolled
Trial Details
Trial ID
NCT05316363
Start Date
December 11 2012
End Date
January 8 2015
Last Update
April 7 2022
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.